Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada

Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada

Abstract Background For novel cancer treatments, effectiveness in clinical practice is not always aligned with clinical efficacy results. As such it is important to understand a treatment’s real-world effectiveness. We examined real-world population-based comparative effectiveness of second-line ipi...

Full description

Bibliographic Details
Main Authors: Wei Fang Dai, Jaclyn M. Beca, Ruth Croxford, Wanrudee Isaranawatchai, Ines B. Menjak, Teresa M. Petrella, Nicole Mittmann, Craig C. Earle, Scott Gavura, Timothy P. Hanna, Kelvin K.W. Chan
Format: Article
Language:English
Published: BMC 2020-04-01
Series:BMC Cancer
Subjects:
Real-world
Comparative effectiveness
Metastatic melanoma
Immunotherapy
Online Access:http://link.springer.com/article/10.1186/s12885-020-06798-1

Internet

http://link.springer.com/article/10.1186/s12885-020-06798-1

Similar Items